Subscribe

Risk Factors of Jabbour et al for Outcome in a Patient with Ph+ Chronic Myeloid Leukemia (CML) in Chronic Phase Treated with Nilotinib After Imatinib

Specialty:

Hematology Oncology

Objective:

ICD-10:

Description:

Jabbour et al evaluated factors affecting the response of patient with Ph+ chronic myeloid leukemia (CML) in chronic phase to nilotinib. The authors are from multiple hospitals in the Europe and North America.

To read more or access our algorithms and calculators, please log in or register.

RECENT TWEETS

medal descover
medal iphone